This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Holly Kordasiewicz, Ph.D.
Vice President Neurology Research at Ionis Pharmaceuticals


Dr. Holly Kordasiewicz is Vice President of Neurology Research at Ionis Pharmaceuticals, a company that specializes in RNA therapeutics.  Dr. Kordasiewicz leads the neurology research team focused on identifying antisense oligonucleotide therapeutics for currently untreatable neurological diseases, including drugs now in clinical trials for ALS, Alzheimer’s disease, and Parkinson’s disease.  Dr. Kordasiewicz joined Ionis 10 years ago after completing her post-doctoral fellowship in the laboratory of Dr. Don Cleveland at the University of California at San Diego where she worked to developing therapies for Huntington’s disease.  Dr. Kordasiewicz began her work on understanding neurological diseases at the University of Minnesota, where she received her Ph.D. in Neuroscience.

Agenda Sessions

  • Antisense Oligonucleotides for the Treatment of Neurological Diseases